Chinese Pharma Co. Seeks OK Of $40M Arbitral Award
A Chinese pharmaceutical company on Wednesday asked a New York federal judge to enforce a $40 million arbitral award stemming from the breach of an investor rights agreement by a urologist...To view the full article, register now.
Already a subscriber? Click here to view full article